Promising novel therapies for relapsed and refractory testicular germ cell tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Promising novel therapies for relapsed and refractory testicular germ cell tumors

Published:2020-11-02 Issue:1 Volume:21 Page:53-69
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Kozakova Kristyna¹²,Mego Michal²³,Cheng Liang⁴⁵,Chovanec Michal²³

Affiliation:

1. Department of Anesthesiology and Intensive Care Medicine, National Cancer Institute, Bratislava, Slovakia

2. 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia

3. Division of Hematology Oncology, Indiana University Simon Cancer Center, Indianapolis, IN, USA

4. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

5. Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA

Funder

Slovak Research and Development Agency

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2021.1838279

Reference173 articles.

1. Current pharmacotherapy for testicular germ cell cancer

2. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

3. Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice

4. Molecular characterization of testicular germ cell tumors: chasing the underlying pathways

5. Genomic landscape of platinum resistant and sensitive testicular cancers

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Pathology of Testicular Cancer;Molecular Surgical Pathology;2023

2. Cisplatin for cancer therapy and overcoming chemoresistance;Heliyon;2022-09

3. Is it possible to achieve long‐term survival in relapsed intracranial non‐germinomatous germ cell tumours?;Pediatric Blood & Cancer;2022-06-23

4. Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines;International Journal of Molecular Sciences;2021-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3